Details

Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients’ data with long-term follow-up.

Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients' data with long-term follow-up. Publié dans European Heart Journal, le 24 janvier 2007. En savoir plus en consultant le site. Auteurs : Montalescot G, Antoniucci D, Kastrati A, Neumann FJ, Borentain M, Migliorini A, Boutron C, Collet JP, Vicaut E. Abstract AIMS:…
Details

A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: the ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) trial.

A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: the ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) trial. Publié dans Journal of the American College of Cardiology, le 05 septembre 2006. En savoir plus en consultant le site.…
Details

Comparison of effects on markers of blood cell activation of enoxaparin, dalteparin, and unfractionated heparin in patients with unstable angina pectoris or non-ST-segment elevation acute myocardial infarction (the ARMADA study).

Comparison of effects on markers of blood cell activation of enoxaparin, dalteparin, and unfractionated heparin in patients with unstable angina pectoris or non-ST-segment elevation acute myocardial infarction (the ARMADA study). Publié dans American Journal of Cardiology, le 15 avril 2003. En savoir plus en consultant le site. Auteurs : Montalescot G, Bal-dit-Sollier C, Chibedi D, Collet…
Details

Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction.

Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. Publié dans New England Journal of Medecine, le 21 juin 2001. En savoir plus en consultant le site. Auteurs : Montalescot G, Barragan P, Wittenberg O, Ecollan P, Elhadad S, Villain P, Boulenc JM, Morice MC, Maillard L, Pansiéri M, Choussat R, Pinton P; ADMIRAL…